Cyient Limited

“Cyient is a competent mid-tier ER&D outsourcer with a durable but narrow moat in aerospace and rail, a clean balance sheet, and honest FCF — but it is not an exceptional compounder. At 14.2x forward earnings it is genuinely cheap, embedding only a ~10% growth assumption on a business capable of 10-12% earnings CAGR, and the probability-weighted return to 2031 is an attractive ~18% CAGR. However, conviction is capped by a persistent quality gap versus domestic peers, a 20-25% tail risk from AI-driven ER&D demand compression over the decade, communications-recovery guidance that has repeatedly missed, and mixed M&A returns. The right posture is to track — own a small starter position if desired, but hold back meaningful capital until communications inflects, AI impact is clearer in reported financials, and DLM reaches standalone viability.”